Company intelligence / Profile preview

Terraplasma Medical

Garching (near Munich), Bavaria, Germany

Ownership: Private
Employees: ~8
Development stage: Other

Overview

The company's CE-certified plasma care® device has demonstrated efficacy in inactivating bacteria (including multi-resistant pathogens), viruses, fungi, and spores, with supportive clinical data from post-market surveillance studies and ongoing multicenter trials for chronic wound infection treatment. The product is in clinical use since 2019 with demonstrated safety and wound healing benefits.

Therapeutic areas: Infectious DiseasesDermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Lacon Electronic (manufacturing partner)Max Planck Society/Max Planck Innovation (technology, R&D support)

Beyond the preview

Go deeper on Terraplasma Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terraplasma Medical.

Explore the full profile